FindTrial
Sign In

A clinical research of a drug combination for the treatment of dermatitis and eczema

A clinical research of a drug combination for the treatment of dermatitis and eczema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004331
Enrollment
Unknown
Registered
2014-02-14
Start date
2014-02-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis and eczema

Interventions

1:drug combination
2:use A only
3:use B only
4:use C only

Sponsors

Ningxia Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients should be in line with eczema diagnosis standard set by Hanifin and Rajka,and have not accepted systemic immunomodulatory drugs, such as corticosteroids in recent two weeks, and antihistamines in recent three days.

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic diseases,or mental diseases, blood diseases,cardiovascular diseases,and during treatment of other drugs; 2. Pregnant women and lactating women; 3. Patients with aldosterone ketosis,myopathy or hypokalemia symptom etc.

Design outcomes

Primary

MeasureTime frame
EASI score;—

Countries

China

Contacts

Public ContactHuijuan Shi

Ningxia Medical University General Hospital

shjyjm@163.com+86 13995295912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026